We propose a data-matching approach to estimate intervention efficacy for randomised controlled trials (RCTs) when there is non-compliance to the allocated treatment with induced selection bias.
Introduction
Randomised controlled trials (RCTs) are considered the gold standard in clinical research for their potential to reduce bias through randomisation such that participants in the study arms have similar characteristics and any difference in outcomes between the study arms can be attributed to the intervention under study [1, 2] . However, selection bias can occur when individuals are requested to give consent for participation in a trial and when individuals are assigned to a treatment arm once they have been accepted into a trial [3] [4] [5] [6] [7] [8] . The former kind of selection bias may result in an over-representation of relatively advantaged participants (such as individuals with higher socio-economic status) who agree to participate in a trial; it can be reduced by randomisation but has impact on interpretation and generalisation of findings [9] . Conversely, the second kind of selection bias cannot be reduced by randomisation as it occurs after the assignment of treatment arms, inducing a serious impact on estimating intervention effects due to non-compliance with assigned treatments [10] . The situation may be complicated further by ethics approval requirements and new rulings in conducting clinical research [3] . An "opt-out" approach (contact was made unless individuals indicated unwillingness to participate) ensures a better response rate by following up nonresponse to an initial invitation [11] . Also, there may be an "opt-in" strategy for giving the participants assigned to the control group the opportunity to receive the same active treatment as those in the intervention group. When participants do not adhere to the protocol of the assigned treatment due to selection bias, the estimation of intervention effects and interpretation are not straightforward.
The most widely-used approach in estimating intervention effects is intention-to-treat (ITT), where treatment comparisons are based on the assigned treatment arms, regardless of whether the participants complied with the treatment. While ITT analysis preserves the benefits of randomisation, it provides valid measures of the intervention "effectiveness" rather M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 than the treatment "efficacy" (the effectiveness of an intervention when it is in fact taken) about which many researchers want to know. The ITT analysis can be adjusted for noncompliance to estimate intervention efficacy using the randomisation indicator as an instrumental variable (IV) [10, [12] [13] [14] . Alternatively, per-protocol (PP) and as-treated (AT) analyses are simple approaches to estimate treatment efficacy, but they are subject to selection bias [10] . Many studies have identified strong selection bias in RCTs [3] [4] 7, 9] . However, besides the proposal of allocation concealment and masking [15] [16] [17] , few studies consider an appropriate way to correct for selection bias due to non-compliance in estimating intervention effects. How these methods (ITT with or without IV adjustment, PP, or AT) influence the comparison of treatments remains unclear, especially, when non-compliance of assigned treatment protocols and selection bias exist. In this paper, we propose a new approach with the use of "nearest-neighbour" matched data to identify compliant participants in both arms and hence to estimate intervention efficacy for RCTs with opt-in and/or opt-out recruitment strategies. Novelty lies in the idea of identifying compliant participants in both arms by datamatching on the basis of participants with known compliance information, not the matching method itself.
Methods

Setting
The Costs to Australian Private Insurance -Coaching Health (CAPICHe) is a parallel-group RCT of the relative impact of telephonic health-coaching support on healthcare cost and utilisation of participants in a disease-management program in Australia [18, 19] . The trial 
Randomisation, recruitment, and intervention program
Participants who met the inclusion criteria were randomly selected from Bupa Australia claims database. Independently of Bupa Australia, the samples were then randomised into the intervention or control groups in a 4:1 ratio stratified by five diagnosed chronic condition [18] . The effectiveness of randomisation for each batch of data was checked. The participants allocated to the intervention group were eligible to receive disease-management services provided by Bupa Health Dialog [19] . An opt-out approach (contact was made unless they contacted the intervention provider to signal unwillingness to participate) was adopted for recruitment.
In the control group, the participants received a letter outlining the services from Bupa Health Dialog. These participants received usual care but were given the opportunity, via mail, to opt-in to receive health coaching. Opt-in participants received the same services as that provided to a participant assigned to the intervention group. Health coaches had the same quality of information available about the members and had all the same educational resources at their disposal as they did for the intervention group. Other than participants in the usual-care arm who opted-in to the intervention and received health coaching, the health coaches were blind to whether participants were in the CAPICHe intervention group or were receiving health coaching as part of the usual business for Bupa [19] .
Outcome measures are non-maternity healthcare costs and hospital length-of-stay 12 months post randomisation, presented as a value and a percentage of difference. Our approach to addressing selection bias due to non-compliance of assigned treatment involved two data-matching on the basis of participants with known compliance information, as indicated by the hollow arrows in Figure 1 . The correction of selection bias was implemented by considering three levels of "principal compliance" corresponding to "Always-takers", "Compliant participants", and "Never-takers" [10] . This approach is in contrast to the inverse-probability-weighting (IPW) method that has been used in RCTs in which data on compliance are missing [20] . As illustrated in Figure 1 , always-takers in the control group (Cell A) are participants who opted in to receive coaching (n=153 out of 8, 883 randomised to the control group), whereas the participants who did not engage (n=8,730) were either compliant participants (Cell B) or never-takers (Cell C). As the principalcompliance levels of these 8,730 participants were not observable, the actual numbers of participants in Cells B and C were unknown. In the intervention group, engaged participants (n=15,375) were either always-takers (Cell D) or compliant participants (Cell E), while nevertakers (Cell F, n=20,160) are participants who did not engage in the program. With the same reason above, the actual numbers of participants in Cells D and E were unknown. For RCTs that adopt opt-in and/or opt-out recruitment strategies, it is anticipated that there would be selection bias in those participants who engaged in health coaching and likely to be associated with higher costs or longer hospital stay in the follow-up period. 
Methodology and statistical methods
data-matching approach, the ITT (with or without adjustment using the randomisation indicator as an IV [10, [12] [13] [14] ), PP, and AT methods, where
and where denotes the proportion of samples with principal compliance (p) in the randomised group (r). From (1) and (4), it can be seen that the data-matching approach estimates treatment efficacy by restricting analysis to participants who comply with the assigned allocation (like PP analysis) and simultaneously correcting for selection bias from always-and never-takers due to non-compliance (Cell D and Cell C in Figure 1 ).
To adjust for baseline covariates, zero-inflated regression models [19, 23, 24] were adopted to estimate the intervention efficacy on healthcare costs and hospital length-of-stay between compliant participants (Cells B and E) identified using the data-matching approach.
Regression covariates were historical costs and admission counts, age, gender, state of residence, randomisation batch, as well as the diagnosed chronic condition, the count of chronic conditions, and the proportion of admissions due to surgical treatment within the follow-up period. Outcome measures with incomplete follow-up were adjusted in the analyses using the observed days of follow-up as exposure risk [19] . Covariates with a p-value greater than 0.05 were removed from the models. Analyses were undertaken in Stata IC 13.1;
StataCorp, College Station, TX.
Results
The study enrolled a total of 44,418 participants, of whom 35,535 participants (80%) were allocated to the CAPICHe intervention group and 8,883 participants (20%) were allocated to
the usual-care control group. The randomisation of treatment groups was effective, as there were no major differences in baseline characteristics (including age group, gender, state of residence, historical healthcare cost and frequency of admissions for the prior 12 months to randomisation) between the two groups; detailed baseline characteristics of participants are reported elsewhere [19] . Table 1 presents the dose-response relationship. Strong selection bias was observed in that participants with higher engagement levels in health coaching were also associated with significantly higher costs or longer hospital length-of-stay within 12 months post randomisation.
( Table 1 here)
The average healthcare costs 12 months post randomisation for the three levels of principal compliance after data-matching were presented in Figure 2 . The trend of increasing costs for never-takers, compliant participants, and always-takers confirmed the existence of strong selection bias. It can be observed that always-takers in the control group had higher costs compared to those in the intervention group, while never-takers in the intervention group had higher costs compared to those in the control group.
The crude estimation of intervention efficacy on the healthcare cost was summarised in versus those who did not (Cells B, C, F; $4,571); an additional cost of $780, or 17.1%). In the presence of selection bias, biased estimation of intervention efficacy was obtained with the PP and AT analyses because it involved comparisons across the three levels of principal compliance (see shaded cells in Figure 1 ). Comparing compliant participants between Cells B and E, the intervention efficacy was $5,332 versus $6,080 (a saving of $748, or 12.3%).
( Figure 2 here) ( Table 2 here)
The baseline characteristics of compliant participants in Cells B and E are different, providing further support of the hypothesis that there would be selection bias in those participants who choose to opt-in or opt-out (see Supplementary Table 1 ). ( Table 3 here) coaching trial. This is important information to policy makers and health planners, by knowing the benefit from offering the intervention program to individuals (who may not adhere to treatment protocols). In this trial, 56.7% of participants assigned to the intervention group did not engage in any health coaching. Many researchers thus also want to know the efficacy of the treatment effect when it is in fact taken. While the ITT analysis can be adjusted for non-compliance using the IV method to estimate intervention efficacy, the IV method requires the "exclusion restriction" assumption that mean effects (healthcare costs in this example) are the same between the intervention and control groups for always-takers (Cells A and D) as well as never-takers (Cells C and F) [10, 12] . According to our findings displayed in Figure 2 , these assumptions, however, are not valid. The PP and AT analyses were also inappropriate as they suffered from selection bias by comparing participants across different compliance levels. Also, it is expected that the PP analysis tends to give, on average, higher estimates of intervention effect than the ITT analysis, especially in RCTs with dropouts [25] [26] [27] [28] . But the findings obtained in this trial indicated the opposite because of the strong selection bias due to non-compliance (see Table 2 ). We proposed the matching approach to correct for selection bias due to non-compliance by identifying compliant participants in the intervention and control groups, with whom the intervention efficacy was estimated. We found that, after adjustment of baseline covariates, the total healthcare costs in the intervention group were $107 (95% CI: -$241 to $455) lower than the control group, representing a 2.0% ($107 of $5440) reduction in cost (p=0.546). Moreover, the total cost due to same-day admissions was lower ($81 or 13.6%; 95% CI: $38-$125 or 7.3%-20.0%; p<0.001) and the hospital length-of-stay was shorter (0.527 days or 11.2%; 95% CI: 0.081-0.974 or 2.6%-19.9%; p=0.021) in the intervention group compared to the control group. evidence-based practices. While well-planned trial designs with proper allocation concealment and masking certainly help to minimise selection bias [15] [16] [17] , it is still required in the analysis to correct for selection bias due to different compliance levels of participants, as selection bias may not be fully removed by adjustment for covariates [10] . Our findings demonstrated strong selection bias in compliance with reference to assigned treatment arms when opt-in and opt-out methods were in place. As illustrated by this health-coaching trial, there is a tendency for participants with higher engagement levels to be associated with higher healthcare costs in the follow-up period (differences across: engagement levels, Table 1; compliance levels, Figure 2 ). Always-takers in the control group who opted in to receive coaching had the highest healthcare costs among the participants in the control group, whereas never-takers in the intervention group who opted out of coaching engagement had the lowest healthcare costs relative to other participants in the intervention group (Figure 2) .
Discussion
Estimation of intervention efficacy in
Differences within compliance levels were also found: Always-takers in the control group had higher healthcare costs compared to those in the intervention group, whereas never-takers in the intervention group had higher healthcare costs relative to those in the control group. These findings will have great impact on the choice of analysis methods for estimating intervention efficacy in RCTs with strong selection bias due to non-compliance.
Strengths and limitations
This is a large RCT for health coaching in chronic-disease management, with 44,418 participants in five preselected diagnosed chronic conditions. Previous trials either had relatively smaller sample sizes or focussed only on one specific condition [29] [30] [31] . With large sample sizes, our trial had sufficient power to detect true differences between the treatment arms if present. Detailed evaluation of the effectiveness of this disease-management program on healthcare cost and utilisation of participants using the ITT analysis with adjustment for baseline covariates was reported elsewhere [19] , which provides important information to can be found. However, further sensitivity analyses are required to study the impact of the uncertainty in compliance information within this latter matching process on treatment comparisons for these more general RCTs.
Implications
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A C C E P T E D ACCEPTED MANUSCRIPT 14 In conducting RCTs, the selection bias arising from the opt-in and/or opt-out recruitement strategies cannot be reduced by the means of randomisation and must be corrected for in the analysis in order to obtain a bias-corrected estimate of intervention effects. Our method is able to identify (nearest-neighbour) participants from participants in the other treatment arm with observed compliance levels, thus enables the estimation of intervention efficacy by comparing outcomes of participants who adhere to the protocol of the allocated treatment in both arms. Our findings are useful for the analysis of future RCTs, where strong selection bias due to non-compliance is anticipated.
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